Role of downregulation of galectin-9 in the tumorigenesis of gastric cancer

International Journal of Oncology

Volumn 45, Issue 3, 2014, Pages 1313-1320

  Yang, Jiaxing ^a   Zhu, Lin ^a   Cai, Yong ^a   Suo, Jian ^a   Jin, Jingji ^a  

^a JILIN UNIVERSITY   (China)

Author keywords

Galectin 9; Gastric cancer; Gene expression; Tim 3

Indexed keywords

ECALECTIN; MESSENGER RNA; GALECTIN; HAVCR2 PROTEIN, HUMAN; LGALS9 PROTEIN, HUMAN; MEMBRANE PROTEIN;

AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CANCER TISSUE; CELL DIFFERENTIATION; CLINICAL ARTICLE; DISTANT METASTASIS; DOWN REGULATION; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MALE; POLYMERASE CHAIN REACTION; PRIMARY TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; STOMACH CARCINOGENESIS; SURVIVAL TIME; WESTERN BLOTTING; ADULT; GENE EXPRESSION REGULATION; GENETIC ASSOCIATION; GENETICS; METABOLISM; MIDDLE AGED; PATHOLOGY; STOMACH TUMOR; TUMOR CELL LINE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CELL LINE, TUMOR; DOWN-REGULATION; FEMALE; GALECTINS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC ASSOCIATION STUDIES; HUMANS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; STOMACH NEOPLASMS;

EID: 84904385885     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2014.2494     Document Type: Article

References (27)

1. Barondes SH, Castronovo V, Cooper DN, Cummings RD, Drickamer K, Felzi T, Gitt MA, Hirabayashi J, Hughes C, Kasai K, Leffler H, Liu FT, Lotan R,Mercurio AM, Monsigny M, Pillai S, Poirer F, Raz A, Rigby PW, Rini JM and Wang JL: Galectins: a family of animal β-galactoside-binding lectins. Cell 76: 597-598, 1994. (Pubitemid 24070645)
2. Leffler H, Carlsson S, Hedlund M, Qian Y and Poirier F: Introduction to galectins. Glycoconj J 19: 433-440, 2004. (Pubitemid 38316516)
3. Hirabayashi J and Kasai K: The family of metazoan metal-independent beta-galectoside-binding lectins: structure, function and molecular evolution. Glycobiology 3: 297-304, 1993. (Pubitemid 23281277)
4. Heusschen R, Griffioen AW and Thijssen VL: Galectin-9 in tumor biology: a jack of multiple trades. Biochim Biophys Acta 1836: 177-185, 2013.
5. Türeci O, Schmitt H, Fadle N, Pfreundschuh M and Sahin U: Molecular definition of a novel human galectin which is immunogenic in patients with Hodgkin's disease. J Biol Chem 272: 6416-6422, 1997. (Pubitemid 27118120)
6. Oda Y, Herrmann J, Gitt MA, Turck CW, Burlingame AL, Barondes SH and Leffler H: Soluble lactose-binding lectin from rat intestine with two differentcarbohydrate-binding domains in the same peptide chain. J Biol Chem 268: 5929-5939, 1993. (Pubitemid 23090929)
7. Hadari YR, Paz K, Dekel R, Mestrovic T, Accili D and Zick Y: Galectin-8. A new rat lectin, related to galectin-4. J Biol Chem 27: 3447-3453, 1995.
8. Sato M, Nishi N, Shoji H, Seki M, Hashidate T, Hirabayashi J, Kasai Ki K, Hata Y, Suzuki S, Hirashima M and Nakamura T: Functional analysis of the carbohydrate recognition domains and a linker peptide of galectin-9 as to eosinophil chemoattractant activity. Glycobiology 12: 171-197, 2002.
9. Oh JH, Yang JO, Hahn Y, Kim MR, Byun SS, Jeon YJ, Kim JM, Song KS, Noh SM, Kim S, Yoo HS, Kim YS and Kim NS: Transcriptome analysis of human gastric cancer. Mamm Genome 16: 942-954, 2005. (Pubitemid 41759837)
10. Zhang F, Zheng M, Qu Y, Li J, Ji J, Feng B, Lu A, Li J, Wang M and Liu B: Different roles of galectin-9 isoforms in modulating E-selectin expression and adhesion function in LoVo colon carcinoma cells. Mol Biol Rep 36: 823-830, 2009.
11. Kageshita T, Kashio Y, Yamaguchi A, Seki M, Abedin MJ, Nishi N, Shoji H, Nakamura T, Ono T and Hirashima M: Possible role of galectin-9 in cell aggregation and apoptosis of human melanoma cell lines and its clinical significance. Int J Cancer 99: 809-816, 2002. (Pubitemid 34575697)
12. Lu LH, Nakagawa R, Kashio Y, Ito A, Shoji H, Nishi N, Hirashima M, Yamaguchi A and Nakamura T: Charaterization of galectin-9-induced death of Jurkat T cells. J Biochem 141: 157-172, 2007. (Pubitemid 46775753)
13. Kobayashi T, Kuroda J, Ashihara E, Oomizu S, Terui Y, Taniyama A, Adachi S, Takagi T, Yamamoto M, Sasaki N, Horiike S, Hatake K, Yamauchi A, Hirashima M and Taniwaki M: Galectin-9 exhibits anti-myeloma activity through JNK and p38 MAP kinase pathways. Leukemia 24: 843-850, 2010.
14. Kashio Y, Nakamura K, Abedin MJ, Seki M, Nishi N, Yoshida N, Nakamura T and Hirashima M: Galectin-9 induces apoptosis through the calcium-calpain- caspase-1 pathway. J Immunol 170: 3631-3636, 2003. (Pubitemid 36359232)
15. Irie A, Yamauchi A, Kontani K, Kihara M, Liu D, Shirato Y, Seki M, Nishi N, Nakamura T, Yokomise H and Hirashima M: Galectin-9 as a prognostic factor with antimetastatic potential in breast cancer. Clin Cancer Res 11: 2962-2968, 2005. (Pubitemid 40525199)
16. Zhang ZY, Dong JH, Chen YW, Wang XQ, Li CH, Wang J, Wang GQ, Li HL and Wang XD: Galectin-9 acts as a prognostic factor with antimetastatic potential in hepatocellular carcinoma. Asian Pac J Cancer Prev 13: 2503-2509, 2012.
17. Liang M, Ueno M, Oomizu S, Arikawa T, Shinonaga R, Zhang S, Yamauchi A and Hirashima M: Galectin-9 expression links to malignant potential of cervical squamous cell carcinoma. J Cancer Res Clin Oncol 134: 899-907, 2008.
18. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL and Trotti A: AJCC Cancer Staging Manual. 7th edition. Springer, Chicago, IL, 2010.
19. Zhu C, Anderson AC, Schubart A, Xiong H, Imitola J, Khoury SJ, Zheng XX, Strom TB and Kuchroo V: The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity. Nat Immunol 6: 1245-1252, 2005. (Pubitemid 43045636)
20. Cooper DN and Barondes SH: God must love galectins; he made so many of them. Glycobiology 9: 979-984, 1999. (Pubitemid 29473954)
21. Vyakarnam A, Dagher SF, Wang JL and Patterson RJ: Evidence for a role for galectin-1 in pre-mRNA splicing. Mol Cell Biol 17: 4730-4737, 1997. (Pubitemid 27318148)
22. Kuwabara I, Kuwabara Y, Yang RY, Schuler M, Green DR, Zuraw BL, Hsu DK and Liu FT: Galectin-7 (PIG1) exhibits pro-apoptotic function through JNK activation and mitochondrial cytochrome c release. J Biol Chem 277: 3487-3497, 2002. (Pubitemid 34953218)
23. Yang RY, Hsu DK, Yu L, Ni J and Liu FT: Cell cycle regulation by galectin-12, a new member of the galectin superfamily. J Biol Chem 276: 20252-20260, 2001.
24. Elola MT, Wolfenstein-Todel C, Troncoso MF, Vasta GR and Rabinovich GA: Galectins: matricellular glycan-binding proteins linking cell adhesion, migration, and survival. Cell Mol Life Sci 64: 1679-1700, 2007. (Pubitemid 47036942)
25. Jiang J, Jin MS, Kong F, Cao D, Ma HX, Jia Z, Wang YP, Suo J and Cao X: Decreased galectin-9 and increased Tim-3 expression are related to poor prognosis in gastric cancer. Plos One 8: e81799, 2013.
26. Monney L, Sabatos CA, Gaglia JL, Ryu A, Waldner H, Chernova T, Manning S, Greenfield EA, Coyle AJ, Sobel RA, Freeman GJ and Kuchroo VK: Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease. Nature 415: 536-541, 2002. (Pubitemid 34130609)
27. Tang ZH, Liang S, Potter J, Jiang X, Mao HQ and Li Z: Tim-3/galectin-9 regulate the homeostasis of hepatic NKT cells in a murine model of nonalcoholic fatty liver disease. J Immunol 190: 1788-1796, 2013.